Michael Kauffman, MD from Karyopharm Therapeutics Inc discusses additional combinations with Selinexor & pomalidomide, revlimid, daratumumab at the 2017 American Society of Hematology.
Michael Kauffman, MD from Karyopharm Therapeutics Inc discusses additional combinations with Selinexor & pomalidomide, revlimid, daratumumab at the 2017 American Society of Hematology.